219 related articles for article (PubMed ID: 7729299)
1. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
[TBL] [Abstract][Full Text] [Related]
2. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D
Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
[TBL] [Abstract][Full Text] [Related]
5. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy.
Vinik AI; Leichter SB; Pittenger GL; Stansberry KB; Holland MT; Powers AC; Suwanwalaikorn S
Diabetes Care; 1995 Sep; 18(9):1225-32. PubMed ID: 8612435
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
12. Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.
Sundkvist G; Velloso LA; Kämpe O; Rabinowe SL; Ivarsson SA; Lilja B; Karlsson FA
Diabetologia; 1994 Mar; 37(3):293-9. PubMed ID: 8174844
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy.
Muhr D; Mollenhauer U; Ziegler AG; Haslbeck M; Standl E; Schnell O
Diabetes Care; 1997 Jun; 20(6):1009-12. PubMed ID: 9167116
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]